Skip to main contentAll experts

ProfessorZachary Whinnett

Professor of Cardiology

National Heart & Lung Institute - Faculty of Medicine

  • Professor of Cardiology
    National Heart & Lung Institute - Faculty of Medicine
  • South- NHLI Cardiovascular Science, Block B Hammersmith Hospital, Hammersmith Campus, United Kingdom

GRANTS

  • STANDARD - CALL
    BRC Cardiovascular Theme Budget Allocation (2022-2027)
    Imperial College Healthcare NHS Trust- BRC Funding1 Dec 2022 - 31 Mar 2028
    Imperial College Healthcare NHS Trust- BRC Funding: BRC Cardiovascular Theme Budget Allocation (2022-2027) (2022-2028)
  • GRANT
    Investigation of the physiological mechanisms through which ventricular tachycardia impairs cardiac function and exploration of potential clinical applicable therapy to improve cardiac output during VT.
    British Heart Foundation1 Apr 2016 - 31 Mar 2019
    BHF: Investigation of the physiological mechanisms through which ventricular tachycardia impairs cardiac function and exploration of potential clinical applicable therapy to improve cardiac output during VT. (2016-2019)
  • GRANT
    AV optimisation delivered with direct His bundle pacing, in patients with heart failure, long PR and normal QRS duration: randomised multi-centre clinical outcome study.
    British Heart Foundation1 Jan 2016 - 31 Jan 2021
    BHF: AV optimisation delivered with direct His bundle pacing, in patients with heart failure, long PR and normal QRS duration: randomised multi-centre clinical outcome study. (2016-2021)
  • GRANT
    Evaluation of mechanisms and quantification of scope for innovation in biventricular pacing
    British Heart Foundation1 Oct 2013 - 30 Sep 2017
    BHF: Evaluation of mechanisms and quantification of scope for innovation in biventricular pacing (2013-2017)
  • CLINICAL TRIAL
    PROTECT-HF: Physiological Vs Right ventricular pacing Outcome Trial Evaluated for bradyCardia Treatment
    British Heart Foundation
    BHF: PROTECT-HF: Physiological Vs Right ventricular pacing Outcome Trial Evaluated for bradyCardia Treatment (2023-2029)